Oncology
Could Gilead’s Trodelvy be the next TROP-2 therapy game-changer in NSCLC treatment?
At the recent IASLC 2023 World Conference on Lung Cancer (WCLC23), Gilead Sciences announced encouraging results from its Phase II…
Medicenna to expand Phase III glioblastoma trial globally
Medicenna Therapeutics is approaching other regulatory agencies outside the US to expand its upcoming Phase III trial in recurrent glioblastoma…
Mendus shows early comparability data for its universal cancer vaccine
Mendus has announced that the immune response triggered by vididencel was comparable for patients with acute myeloid leukaemia (AML) and…
1ST Biotherapeutics and Merck to assess cancer combination treatment
1ST Biotherapeutics has signed a clinical trial collaboration and supply agreement with Merck & Co (MSD) to assess FB849 plus Keytruda (pembrolizumab)…
Boundless Bio collaborates with Lilly for Phase I/II solid tumour trial
Boundless Bio has announced a collaboration with Eli Lilly for its first-in-human Phase I/II trial investigating BBI-355 in solid tumours.…
ImmPACT Bio begins dosing in Phase I/II lymphoma therapy trial
US-based biotechnology company ImmPACT Bio has dosed the first patient in its Phase I/II clinical trial of IMPT-314 for relapsed or…
Boundless Bio and Taiho to assess cancer combo therapy in Phase I/II trial
Boundless Bio has signed a clinical trial collaboration and supply agreement with Taiho Oncology to evaluate the combination of BBI-355…
Lisata treats first patient in BOLSTER trial of solid tumours therapy
Lisata Therapeutics has treated the first patient in the head and neck squamous cell carcinoma (HNSCC) cohort of the Phase…
Nuvectis Pharma kickstarts Phase Ia trial in solid tumours
Nuvectis Pharma will test its solid tumour treatment candidate for the first time in human trials after the biopharma announced…
HUTCHMED concludes enrolment in follicular lymphoma therapy trial
HUTCHMED has concluded the enrolment of 42 patients in a bridging study of tazemetostat to treat relapsed/refractory follicular lymphoma (R/R…